tiprankstipranks
Pharmadrug (TSE:PHRX)
:PHRX
Canadian Market
Want to see TSE:PHRX full AI Analyst Report?

Pharmadrug (PHRX) Financial Statements

33 Followers

Pharmadrug Financial Overview

Pharmadrug's market cap is currently C$1.34M. The company's EPS TTM is C$-0.0043; its P/E ratio is -2.33; Pharmadrug is scheduled to report earnings on May 28, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 7.01K
Gross ProfitC$ -50.24KC$ -50.24KC$ -26.22KC$ -2.26KC$ -2.15K
Operating IncomeC$ -225.93KC$ -668.66KC$ -1.33MC$ -2.43MC$ -2.80M
EBITDAC$ -71.98KC$ -549.04KC$ -1.33MC$ -2.34MC$ -4.21M
Net IncomeC$ -383.38KC$ -793.27KC$ -13.20MC$ -8.88MC$ -5.87M
Balance Sheet
Cash & Short-Term InvestmentsC$ 23.24KC$ 75.04KC$ 423.06KC$ 329.24KC$ 1.30M
Total AssetsC$ 551.66KC$ 711.80KC$ 1.20MC$ 12.11MC$ 19.52M
Total DebtC$ 1.52MC$ 1.35MC$ 1.77MC$ 1.42MC$ 866.37K
Net DebtC$ 1.50MC$ 1.27MC$ 1.36MC$ 1.41MC$ -91.62K
Total LiabilitiesC$ 2.20MC$ 1.96MC$ 2.66MC$ 3.28MC$ 2.66M
Stockholders' EquityC$ -1.76MC$ -1.40MC$ -1.70MC$ 8.84MC$ 16.87M
Cash Flow
Free Cash FlowC$ -87.51KC$ -768.60KC$ -671.88KC$ -2.26MC$ -4.17M
Operating Cash FlowC$ -87.51KC$ -756.62KC$ -671.88KC$ -2.26MC$ -4.13M
Investing Cash FlowC$ 0.00C$ -11.98KC$ 995.04KC$ 77.58KC$ 1.48M
Financing Cash FlowC$ 0.00C$ 321.56KC$ 225.51KC$ 843.25KC$ 776.97K
Currency in CAD

Pharmadrug Earnings and Revenue History

Pharmadrug Debt to Assets

Pharmadrug Cash Flow

Pharmadrug Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.